The GLP-1R is of clinical interest not only due to its physiologic expression and functions in pancreatic islet cells and its established role in the therapy of type 2 diabetes using GLP-1 analogs (Nauck 2016), but also because of its possible role in cancer. The gene discussed is GLP1R; the disease is cancer.